Macrophage-targeted therapies offer new opportunities in inflammation and oncology, but variable cell states, limited delivery precision, and weak tissue models can derail development. Here's how integrated assays can support more informed screening decisions.
Macrophages sit at the crossroads of inflammation, tissue repair, and tumor biology. Their plasticity makes them appealing therapeutic...